These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38068988)

  • 21. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM; Mackie IM
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: implications for management of vascular disorders.
    Mousa SA
    Semin Thromb Hemost; 2000; 26 Suppl 1():39-46. PubMed ID: 11011805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the anticoagulant response of a novel fluorogenic anti-FXa assay with two commercial anti-FXa chromogenic assays.
    Harris LF; O'Brien A; Castro-López V; O'Donnell JS; Killard AJ
    Thromb Res; 2011 Dec; 128(6):e166-70. PubMed ID: 21872908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation.
    Gerotziafas GT; Petropoulou AD; Verdy E; Samama MM; Elalamy I
    J Thromb Haemost; 2007 May; 5(5):955-62. PubMed ID: 17461929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anticoagulant activity of low-molecular-weight heparins obtained using a hydrolase complex].
    Drozd NN; Tolstenkov AS; Bannikova GE; Miftakhova NT; Lapikova ES; Makarov VA; Varlamov VP
    Eksp Klin Farmakol; 2007; 70(6):19-24. PubMed ID: 18318190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran.
    Ammollo CT; Semeraro N; Carratù MR; Colucci M; Semeraro F
    J Pharmacol Exp Ther; 2016 Feb; 356(2):305-13. PubMed ID: 26578266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
    Schroeder M; Hogwood J; Gray E; Mulloy B; Hackett AM; Johansen KB
    Anal Bioanal Chem; 2011 Jan; 399(2):763-71. PubMed ID: 20922518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the levels of unfractionated and low-molecular-weight heparins in plasma: their effect on thrombin-mediated feedback reactions in vivo. Preliminary results after subcutaneous injection.
    Hemker HC; Béguin S; Bendetowicz AV; Wielders S
    Haemostasis; 1991; 21(4):258-72. PubMed ID: 1665467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma.
    Hemker HC; Béguin S
    Haemostasis; 1990; 20 Suppl 1():81-92. PubMed ID: 1964667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin.
    Beumer S; IJsseldijk MJ; de Groot PG; Sixma JJ
    Blood; 1994 Dec; 84(11):3724-33. PubMed ID: 7949128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of thrombin generation by heparin and LMW heparins: a comparison of chromogenic and clotting methods.
    Houbouyan L; Padilla A; Gray E; Longstaff C; Barrowcliffe TW
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):24-30. PubMed ID: 8845459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic activity and its relationship to in vitro anticoagulant effects.
    Gray E; Padilla A; Barrowcliffe TW
    Haemostasis; 1993 Mar; 23 Suppl 1():99-102. PubMed ID: 8388358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays.
    Coppell JA; Thalheimer U; Zambruni A; Triantos CK; Riddell AF; Burroughs AK; Perry DJ
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):97-104. PubMed ID: 16479191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa.
    Lewis J; Iqbal O; Jeske W; Hoppensteadt D; Siddiqui F; Fareed J
    Clin Appl Thromb Hemost; 2022; 28():10760296221099934. PubMed ID: 35535398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of thrombin-receptors of thrombocytes for the interaction of heparins and low-molecular-weight heparin in human whole blood clotting.
    Harenberg J; Schuler M; Zimmermann R; Heptner W
    Haemostasis; 1988; 18 Suppl 3():20-2. PubMed ID: 2840370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.